Gene expression ontology annotations and IPA analyses show that ‘low-repeat’ and ‘high-repeat’ AML patient samples display a similar activation of pattern recognition pathways and interferon response as compared to healthy CD34 + control cells (see Additional file 9: Figure S9), but differ in the dysregulation of other gene expression pathways. Here, CD34 is linked to acute myeloid leukemia.